Home > HP (current issue) > News and research update / News Centre | Search

PJ Online homeHospital Pharmacist
2007;14:245
September 2007

Hospital Pharmacist back issues

News summary


Government to help hospital pharmacists pay retention fee

Pharmacists' retention fees are to be subsidised by £38

Pharmacists’ retention fees are to be subsidised by £38

Hospital pharmacists in England are to benefit from a Government subsidy of their Royal Pharmaceutical Society retention fee, it was announced last month.

As part of an improved pay package worth £52 million, the Department of Health will contribute £38 to professional body registration fees for all health professionals up to band 8a.

David Miller, Chairman of the Guild of Healthcare Pharmacists’ terms and conditions committee, welcomed the proposals, noting that it is the first time the DoH had offered to contribute to professional fees.

However, he added that the offer will do nothing to offset the cost for pharmacists above band 8a, who have been excluded from the offer.

The announcement came at the same time that the Society proposed to increase the retention fee for practising pharmacists to £425 from January next year.

Also included in the DoH pay package is an agreement to pay support staff in bands 1 and 2 an additional £400 per year, while staff in bands 3 and 4 will be given £38 on top of either an increase of 2.5 per cent, or £400, whichever is greater. Staff in bands 5 to 8a have also been offered a 2.5 per cent rise, along with a £38 contribution towards fees.

Details of the pay package can be found at www.dh.gov.uk

See also DoH to help pharmacists pay Society retention fee (PJ 2007;279:144)

The Society has begun a 60-day consultation period regarding its proposed increases to registration and retention fees. Registrants are invited to respond to the proposed changes in the form of a questionnaire that can be accessed via the Society’s website.

Responses to the questionnaire will be analysed by an independent external body. The consultation period ends on 3 October 2007.

Back to Top


©The Pharmaceutical Journal